Status:
COMPLETED
Retrospective Study on the Incidence and Management of Anemia in Oncology
Lead Sponsor:
Weprom
Conditions:
Anemia
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The incidence of anemia ranges from 20 to 75% depending on the type of cancer. It is often present at diagnosis and increases with specific treatments. It has an impact on overall survival and quality...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old,
- Follow-up for cancer justifying hospitalization,
- Presenting anemia defined by a hemoglobin level \<11 g / dL,
- Patient not having objected to the collection of his data after oral and written information.
Exclusion
- patients with a hemoglobin level ≥ 11 g / dL,
- adult patients under guardianship, curatorship or deprived of liberty,
- pregnancy or breast-feeding in progress at the time of hospitalization.
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2021
Estimated Enrollment :
349 Patients enrolled
Trial Details
Trial ID
NCT04779840
Start Date
May 20 2020
End Date
January 20 2021
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Jean Bernard - Clinique Victor Hugo
Le Mans, France, 72000